ES2059352T3 - Utilizacion de hemocianinas y arilforinas para el tratamiento de tumores. - Google Patents

Utilizacion de hemocianinas y arilforinas para el tratamiento de tumores.

Info

Publication number
ES2059352T3
ES2059352T3 ES87118765T ES87118765T ES2059352T3 ES 2059352 T3 ES2059352 T3 ES 2059352T3 ES 87118765 T ES87118765 T ES 87118765T ES 87118765 T ES87118765 T ES 87118765T ES 2059352 T3 ES2059352 T3 ES 2059352T3
Authority
ES
Spain
Prior art keywords
arylphorins
treatment
haemocyanin
hemocyanins
tumors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87118765T
Other languages
English (en)
Inventor
Thomas Dr Stiefel
Harald Dr Porcher
Jurgen Prof Dr Markl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2059352T3 publication Critical patent/ES2059352T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/385Haptens or antigens, bound to carriers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43509Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from crustaceans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031Proteins
    • A61K2039/6081Albumin; Keyhole limpet haemocyanin [KLH]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Insects & Arthropods (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

LA PATENTE AFECTA A LA UTILIZACION DE HEMOCIANINA, EXCEPTO HEMOCIANINA DE KEYHOLE - LIMPET, Y/O ARILFORINA PARA INFLUIR SOBRE EL SISTEMA INMUNOLOGICO Y PARA EL TRATAMIENTO DE TUMORES. SE SABE QUE L HEMOCIANINA KEYHOLE - LIMPET MUESTRA UN EFECTO ANTITUMORAL EN EL CARCINOMA DE VEJIGA SUPERFICIAL. LAS HEMOCIANINAS Y LAS ARILFORINAS, AISLADAS PREFERENTEMENTE DE ANIMALES DE LOS GENEROS CALLIPHORA, HELIX, OCTOPUS, ASTACUS, CARCINUS, LIMULUS Y EURYPELMA, MUESTRAN UNOS EFECTOS INMUNOLOGICOS INHIBIDORES DE TUMORES INESPERADOS, ESPECIALMENTE SI SE UNEN CON OTROS COMPONENTES.
ES87118765T 1987-12-17 1987-12-17 Utilizacion de hemocianinas y arilforinas para el tratamiento de tumores. Expired - Lifetime ES2059352T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP87118765A EP0320528B1 (de) 1987-12-17 1987-12-17 Verwendung von Haemocyaninen und Arylphorinen zur Beeinflussung des Immmunsystems und Behandlung von Tumoren

Publications (1)

Publication Number Publication Date
ES2059352T3 true ES2059352T3 (es) 1994-11-16

Family

ID=8197523

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87118765T Expired - Lifetime ES2059352T3 (es) 1987-12-17 1987-12-17 Utilizacion de hemocianinas y arilforinas para el tratamiento de tumores.

Country Status (6)

Country Link
EP (1) EP0320528B1 (es)
JP (1) JP2709111B2 (es)
AT (1) ATE94073T1 (es)
CA (1) CA1336322C (es)
DE (1) DE3787374D1 (es)
ES (1) ES2059352T3 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69835885T2 (de) * 1998-12-02 2007-01-11 Entopharm Co., Ltd. Immunomodulatorische Mittel aus Calliphora vicina Larven, deren Herstellung und Verwendung
RU2172322C1 (ru) * 1999-12-27 2001-08-20 Энтофарм Ко., Лтд. Аллофероны-иммуномодулирующие пептиды
EP1603405A4 (en) * 2003-03-14 2006-05-24 Foodscience Corp METHOD FOR THE TREATMENT OF CANCER WITH PERNA CANALICULUS INGREDIENTS (EN) AND PERNA CANALICULUS EXTRACTS
US6916908B2 (en) * 2003-07-21 2005-07-12 Alfredo Emilio De Ioannes Product and composition containing a Concholepas concholepas hemocyanin (CCH) subunit, and a method of use thereof
RU2447896C1 (ru) * 2010-11-15 2012-04-20 Общество с ограниченной ответственностью "Аллофарм" Антимикробное вещество

Also Published As

Publication number Publication date
DE3787374D1 (de) 1993-10-14
EP0320528A1 (de) 1989-06-21
EP0320528B1 (de) 1993-09-08
CA1336322C (en) 1995-07-18
JPH01197441A (ja) 1989-08-09
JP2709111B2 (ja) 1998-02-04
ATE94073T1 (de) 1993-09-15

Similar Documents

Publication Publication Date Title
DK0954299T3 (da) Thyroxin-analoger uden signifikant hormonal aktivitet til behandling af ondartede tumorer
BR0012793A (pt) Métodos para indução de angiogênese pela administração de nicotina ou outro agonista de receptor de nicotina
ES2071484T3 (es) Derivados de 2,4-diaminoquinazolinas para aumentar la actividad antitumoral.
DE69427862T2 (de) K-252a derivate, die neurotrophin-induzierte aktivität erhöhen
HUP9904368A2 (hu) Colostrinin és alkalmazása
ES2074565T3 (es) Empleo de melatonina para tratar el sindrome pre-menstrual.
WO1992002240A3 (en) Novel methods and compositions for treatment of angiogenic diseases
DE3888378D1 (de) Behandlung von Prostatacarcinoma mit 17-beta-n-monosubstituierten-Carbamoyl-4-aza-5-alpha-Androst-1-en-3-onen.
ES2153862T3 (es) Bisulfan de administracion parenteral para el tratamiento de enfermedades malignas.
AR008799A1 (es) Composicion de vacuna para prevenir o tratar el paludismo; uso de dicha composicion para elaborar medicamentos y metodo para dicha profilaxis y dichotratamiento
MY108304A (en) N-alkyl-3-phenyl-3-(2-alkylthiophenoxy)propylamines.
ES2059352T3 (es) Utilizacion de hemocianinas y arilforinas para el tratamiento de tumores.
EP0204989A3 (en) Use of penicillamine in the treatment of immune deficiency diseases
DE69332111D1 (de) Darmprotozoen-Impfstoffe
NO891703D0 (no) Farmasoeytiske sammensetninger for behandling av psoriasis.
CZ20012032A3 (cs) Nové způsoby léčby zhoubného bujení
MX9201763A (es) Derivados de pirimidina para aumentar la actividad antitumores.
ATE111357T1 (de) Synergetische immunostimulierende zusammensetzung und ihre verwendung.
SE8900835L (sv) Foerbaettringar i samband med organiska foereningar
MX9201258A (es) Compuestos para el tratamiento del cancer y procedimiento para su preparacion.
DK328088D0 (da) Farmaceutisk komposition til behandling af tumorer
OA08480A (en) Polycylic quinoline, naphthyridine and pyrazinopyridine derivatives.
ES2061775T3 (es) Derivados de estrobirulina, su obtencion y empleo.
ATE363913T1 (de) Verwendung von tcf-ii zur behandlung oder vorbeugung von sepsis
PT1017377E (pt) Utilizacao de 2-aminotetralinas 6,7-substituidas para o tratamento de condicoes inflamatorias mediadas por citoquina

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 320528

Country of ref document: ES